Cyclacel Pharmaceuticals Inc. (NASDAQ: CYCC) Stock Information | RedChip

Cyclacel Pharmaceuticals Inc. (NASDAQ: CYCC) Listen to this Section


$1.29
-0.0300 ( -2.27% ) 153.2K

Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors, and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib, Sapacitabine, and plogosertib.

Market Data


Open


$1.29

Previous close


$1.32

Volume


153.2K

Market cap


$1.86M

Day range


$1.16 - $1.35

52 week range


$1.16 - $11.34

Insider Ownership Transactions

Total Amount Purchased: -4,544.00 | $ -5,861.76

Date Type Amount Purchased Purchaser
2024-01-31 Sale -12500.00 SCHWARTZ BRIAN
2023-12-26 Buy 6070.00 Rombotis Spiro George
2023-12-26 Buy 1886.00 McBarron Paul

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 17 Aug 14, 2024
10-q Quarterly Reports 64 Aug 14, 2024
8-k 8K-related 15 Jun 25, 2024
8-k 8K-related 17 May 14, 2024
10-q Quarterly Reports 61 May 14, 2024
def Proxies and info statements 5 May 08, 2024
ars Annual reports 1 May 08, 2024
8-k 8K-related 24 May 02, 2024
10-k/a Quarterly Reports 16 Apr 29, 2024
8-k 8K-related 14 Apr 26, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.